Skip to main content
Clinical Trials/NCT06546579
NCT06546579RecruitingPhase 1

Sensitivity of Self-collected Skin Sampling for Scabies: a Pilot Study

Radboud University Medical Center1 site in 1 country144 target enrollmentStarted: August 21, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Enrollment
144
Locations
1
Primary Endpoint
The sensitivity of professionally-collected skin samples for diagnosing scabies

Study Overview

Brief Summary

In this cross-sectional diagnostic study, healthy adults aged 18 and older with suspected, clinical, or confirmed scabies will be recruited. The objective is to determine if the sensitivity of self-collected skin samples for scabies diagnosis is non-inferior to professional sampling, and compare the sensitivity and specificity of the polymerase chain reaction assay (PCR) versus microscopy.

Detailed Description

Scabies infestations have significantly increased globally in the last 10-20 years, including a threefold rise in the Netherlands over the past decade. Diagnosing scabies is challenging due to varied symptoms and low sensitivity of current microscopic methods. New diagnostic techniques like PCR, which offer higher sensitivity, are being investigated. The feasibility of self-collected skin samples is being explored to reduce the burden on healthcare services and address issues like autonomy, stigma, and privacy.

In this cross-sectional diagnostic study, healthy adults aged 18 and older with suspected, clinical, or confirmed scabies will be included. Primary endpoint is the sensitivity of self-collected versus professional skin samples for diagnosing scabies. Secondary endpoints include sensitivity of skin scrapings and swabs, and the sensitivity and specificity of PCR versus microscopy.

Participants will self-collect skin samples during a standard care visit. The process may be slightly sensitive but not painful. There are no direct benefits beyond standard care.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •18 years or older
  • •Have either suspected scabies, clinical scabies or confirmed scabies (see table 1)
  • •Providing informed consent (IC)

Exclusion Criteria

  • •Individuals not speaking or understanding the Dutch or English language.
  • •Individuals who have been diagnosed with scabies in the last six weeks and had started treatment.
  • •Individuals who have used ivermectin for other diagnoses than scabies in the last six weeks.
  • •Individuals younger than 18 years.
  • •Individuals with immunosuppressive conditions (see appendix A).
  • •Any other condition, finding or situation which, in the opinion of the investigator, may significantly increase the risk to the individual because of participation in the study, affect the ability of the individual to participate in the study or impair interpretation of the study data.

Arms & Interventions

Experimental group

Experimental

All participants will be asked to perform self-sampling and irrespective of the result will receive current standard-of-care from their health care provider for their suspected scabies.

Intervention: Skin sampling (Diagnostic Test)

Outcomes

Primary Outcomes

The sensitivity of professionally-collected skin samples for diagnosing scabies

Time Frame: through study completion, an average of one year

The proportion of professionally-collected samples collected at the enrolment visit that are tested positive, divided by the total number of participants adjudged retrospectively to have had scabies at their enrolment visit, based on a composite clinical diagnosis.

The sensitivity of self-collected skin samples for diagnosing scabies

Time Frame: through study completion, an average of one year

The proportion of self-collected samples collected at the enrolment visit that are tested positive, divided by the total number of participants adjudged retrospectively to have had scabies at their enrolment visit, based on a composite clinical diagnosis.

Secondary Outcomes

  • The sensitivity of skin swabs for diagnosing scabies(through study completion, an average of one year)
  • The sensitivity of skin scrapings for diagnosing scabies(through study completion, an average of one year)
  • The sensitivity and specificity of PCR on skin scraping for diagnosing active scabies infection(through study completion)
  • The sensitivity and specificity of microscopy on skin scraping for diagnosing active scabies infection(through study completion, an average of one year)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials